ERCC1 and neoplasm: Most interestingly, we discovered the presence of ERCC1+CTC at primary diagnosis to be an independent predictor for platinum-resistance, whereas ERCC1-expression in corresponding primary tumor tissue predicted neither platinum-resistance nor prognosis [15].